A Case of Unresectable Pancreatic Cancer with Long-Term Survival in High-Intensity Focused Ultrasound (HIFU) Therapy

A patient in Tokyo with pancreatic cancer survived more than four years while undergoing focused ultrasound in conjunction with standard systemic chemotherapy.

pancreatic cancer stockJapanese physicians from the Department of Gastroenterology and Hepatology at Tokyo Medical University employed high-intensity focused ultrasound (HIFU) in conjunction with standard systemic chemotherapy to control pain and possibly extend survival in a 63-year-old man with pancreatic cancer. The clinical trial with Yuande Bio-Medical’s ultrasound-guided “FEP-BY 02” HIFU system (Beijing, China) lasted more than three years during which the patient received seven HIFU applications. The patient died 4.5 years after the onset of the disease. Can pain level, tumor size, and tumor biomarkers be used to make treatment decisions regarding when to add focused ultrasound?

See Ultrasound International Open >

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
434.220.4993
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Email